Answers are grounded in this paper and cite their sources.
BackgroundMetabolic dysfunction is a modifiable contributor to cognitive impairment and Alzheimer's disease risk. The cholesterol-HDL-glucose (CHG) index integrates atherogenic dyslipidemia and hyperglycemia, but the cognitive implications of cumulative CHG exposure are unknown.ObjectiveTo examine the association of cumulative CHG (cuCHG) exposure with cognitive trajectories and new-onset mild cognitive impairment (MCI).MethodsAdults aged ≥45 years were drawn from the China Health and Retirement Longitudinal Study (CHARLS, 2011-2020). MCI was defined using ageing-associated cognitive decline criteria. K-means clustering classified longitudinal CHG trajectories, and cuCHG was calculated as [(CHG2012 + CHG2015)/2] × time interval. Linear mixed-effects models assessed cognitive trajectories, and Cox regression with restricted cubic splines evaluated incident MCI risk.ResultsAmong 2646 participants, 404 (15.3%) developed MCI over 5 years. All cognitive domains declined significantly (global cognition β/year = -0.343, 95% CI -0.367 to -0.320; all p < 0.001), but no time × cuCHG interaction was detected (all p > 0.05). In fully adjusted Cox models, the middle-CHG cluster showed 21% lower MCI risk than the low-CHG cluster (HR = 0.79, 95% CI 0.62-0.99, p = 0.043); the high-CHG cluster did not differ. Restricted cubic splines showed a non-linear relationship (p for non-linearity < 0.05), with elevated risk at both extremes. A significant sex interaction was observed (p = 0.015).ConclusionsCumulative CHG exposure showed a non-linear association with incident MCI, with a middle-range trajectory independently associated with lower risk. Balanced metabolic homeostasis, rather than indiscriminately minimizing metabolic indices, may be relevant to cognitive ageing.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: